Try our Advanced Search for more refined results
Searching dockets in Nevakar Inc x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Declaration
[SEALED] DECLARATION of Brett Williamson re 126 Unopposed MOTION for Leave to File Under Seal Plaintiffs' Answering Brief in Opposition to Baxter's Fed. R. Civ. P. 12(b)(6) Motion to Dismiss, Declaration of Brett Williamson and Exhibits., 127 Answering Brief in Opposition,, by Nevakar Injectables Inc., Nevakar Pharmaceuticals Inc., Nevakar, Inc., PH Health Limited, Par Health USA, LLC. (Attachments: # 1 Exhibits A-C)(Tigan, Jeremy)
Brief - Answering Brief in Opposition
[SEALED] ANSWERING BRIEF in Opposition re 126 Unopposed MOTION for Leave to File Under Seal Plaintiffs' Answering Brief in Opposition to Baxter's Fed. R. Civ. P. 12(b)(6) Motion to Dismiss, Declaration of Brett Williamson and Exhibits., 115 MOTION to Dismiss for Failure to State a Claim filed by Nevakar Injectables Inc., Nevakar Pharmaceuticals Inc., Nevakar, Inc., PH Health Limited, Par Health USA, LLC.Reply Brief due date per Local Rules is 10/13/2026. (Tigan, Jeremy)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.